Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: Myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients

Human Gene Therapy

Volumn 15, Issue 3, 2004, Pages 251-262

  Amado, Rafael G ^a,b   Mitsuyasu, Ronald T ^a,b   Rosenblatt, Joseph D ^c   Ngok, Frances K ^a   Bakker, Andreas ^d   Cole, Steve ^a,b   Chorn, Nathalie ^a   Lin, Lii Shin ^a   Bristol, Gregory ^a   Boyd, Maureen P ^e   Macpherson, Janet L ^e   Fanning, Gregory C ^e   Todd, Alison V ^e   Ely, Julie A ^e   Zack, Jerome A ^a,b   Symonds, Geoff P ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Specialty Laboratories   (United States)

^e JOHNSON AND JOHNSON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RETROVIRUS VECTOR; RIBOZYME;

ADULT; ARTICLE; BONE MARROW CELL; CELL LINE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE THERAPY; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOID CELL; MALE; MULTIDRUG RESISTANCE; PHASE 1 CLINICAL TRIAL; T LYMPHOCYTE; TRANSGENE; VIRUS EXPRESSION; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD34; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; MYELOID CELLS; POLYMERASE CHAIN REACTION; RETROVIRIDAE; RNA, CATALYTIC;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 12144291445     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303404322886101     Document Type: Article

References (35)

1. AIUTI, A., SLAVIN, S., AKER, M., FICARA, F., DEOLA, S., MORTELLARO, A., MORECKI, S., ANDOLFI, G., TABUCCHI, A., CARLUCCI, F., MARINELLO, E., CATTANEO, F., VAI, S., SERVIDA, P., MINIERO, R., RONCAROLO, M.G., and BORDIGNON, C. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
2. AMADO, R.G., SYMONDS, G., JAMIESON, B.D., ZHAO, G., ROSENBLATT, J.D., and ZACK, J.A. (1998). Effects of megakaryocyte growth and development factor on survival and retroviral transduction of T lymphoid progenitor cells. Hum. Gene Ther. 9, 173-183.
3. AMADO, R.G., MITSUYASU, R.T., SYMONDS, G., ROSENBLATT, J.D., ZACK, J., SUN, L.Q., MILLER, M., ELY, J., and GERLACH, W. (1999). A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme. Hum. Gene Ther. 10, 2255-2270.
4. BAZIN, H., CHATTOPADHYAYA, J., DATEMA, R., ERICSON, A.C., GILLJAM, G., JOHANSSON, N.G., HANSEN, J., KOSHIDA, R., MOELLING, K., OBERG, B., REMAUD, G., STENING, G., VRANG, L., WAHREN, B., and WU, J.C. (1989). An analysis of the inhibition of replication of HIV and MuLV by some 3′-blocked pyrimidine analogs. Biochem. Pharmacol. 38, 109-119.
5. BENDER, M.A., PALMER, T.D., GELINAS, R.E., and MILLER, A.D. (1987). Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61, 1639-1646.
6. BROOKS, D.G., KITCHEN, S.G., KITCHEN, C.M., SCRIPTURE-ADAMS, D.D., and ZACK, J.A. (2001). Generation of HIV latency during thymopoiesis. Nat. Med. 7, 459-464.
7. CAVAZZANA-CALVO, M., HACEIN-BEY, S., DE SAINT BASILE, G., GROSS, F., YVON, E., NUSBAUM, P., SELZ, F., HUE, C., CERTAIN, S., CASANOVA, J.L., BOUSSO, P., DEIST, F.L., and FISCHER, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288, 669-672.
8. DOUEK, D.C., MCFARLAND, R.D., KEISER, P.H., GAGE, E.A., MASSEY, J.M., HAYNES, B.F., POLIS, M.A., HAASE, A.T., FEINBERG, M.B., SULLIVAN, J.L., JAMIESON, B.D., ZACK, J.A., PICKER, L.J., and KOUP, R.A. (1998). Changes in thymic function with age and during the treatment of HIV infection. Nature 396, 690-695.
9. EMMONS, R.V., DOREN, S., ZUJEWSKI, J., COTTLER-FOX, M., CARTER, C.S., HINES, K., O'SHAUGHNESSY, J.A., LEITMAN, S.F., GREENBLATT, J.J., COWAN, K., and DUNBAR, C.E. (1997). Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 89, 4040-4046.
10. HACEIN-BEY-ABINA, S., VON KALLE, C., SCHMIDT, M., LE DEIST, F., WULFFRAAT, N., MCINTYRE, E., RADFORD, I., VILLEVAL, J.L., FRASER, C.C., CAVAZZANA-CALVO, M., and FISCHER, A. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
11. HANENBERG, H., XIAO, X.L., DILLOO, D., HASHINO, K., KATO, I., and WILLIAMS, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2, 876-882.
12. HASELOFF, J., and GERLACH, W.L. (1988). Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334, 585-591.
13. IGARASHI, T., BROWN, C.R., ENDO, Y., BUCKLER-WHITE, A., PLISHKA, R., BISCHOFBERGER, N., HIRSCH, V., and MARTIN, M.A. (2001). Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans. Proc. Natl. Acad. Sci. U.S.A. 98, 658-663.
14. JAMIESON, B.D., DOUEK, D.C., KILLIAN, S., HULTIN, L.E., SCRIPTURE-ADAMS, D.D., GIORGI, J.V., MARELLI, D., KOUP, R.A., and ZACK, J.A. (1999). Generation of functional thymocytes in the human adult. Immunity 10, 569-575.
15. KNOP, A.E., ARNDT, A.J., RAPONI, M., BOYD, M.P., ELY, J.A., and SYMONDS, G. (1999). Artificial capillary culture: Expansion and retroviral transduction of CD4+ T-lymphocytes for clinical application. Gene Ther. 6, 373-384.
16. KOENIG, S., GENDELMAN, H.E., ORENSTEIN, J.M., DAL CANTO, M.C., PEZESHKPOUR, G.H., YUNGBLUTH, M., JANOTTA, F., AKSAMIT, A., MARTIN, M.A., and FAUCI, A.S. (1986). Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233, 1089-1093.
17. KOHN, D.B., HERSHFIELD, M.S., CARBONARO, D., SHIGEOKA, A., BROOKS, J., SMOGORZEWSKA, E.M., BARSKY, L.W., CHAN, R., BUROTTO, F., ANNETT, G., NOLTA, J.A., CROOKS, G., KAPOOR, N., ELDER, M., WARA, D., BOWEN, T., MADSEN, E., SNYDER, F.F., BASTIAN, J., MUUL, L., BLAESE, R.M., WEINBERG, K., and PARKMAN, R. (1998). T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat. Med. 4, 775-780.
18. KOHN, D.B., BAUER, G., RICE, C.R., ROTHSCHILD, J.C., CARBONARO, D.A., VALDEZ, P., HAO, Q., ZHOU, C., BAHNER, I., KEARNS, K., BRODY, K., FOX, S., HADEN, E., WILSON, K., SALATA, C., DOLAN, C.; WETTER, C., AGUILAR-CORDOVA, E., and CHURCH, J. (1999). A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 94, 368-371.
19. MCELRATH, M.J., PRUETT, J.E., and COHN, Z.A. (1989). Mononuclear phagocytes of blood and bone marrow: Comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. U.S.A. 86, 675-679.
20. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
21. ORENSTElN, J.M., FOX, C., and WAHL, S.M. (1997). Macrophages as a source of HIV during opportunistic infections. Science 276, 1857-1861.
22. OSTROWSKI, M.A., CHUN, T.W., JUSTEMENT, S.J., MOTOLA, I., SPINELLI, M.A., ADELSBERGER, J., EHLER, L.A., MIZELL, S.B., HALLAHAN, C.W., and FAUCI, A.S. (1999). Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J. Virol. 73, 6430-6435.
23. PICKER, L.J., TREER, J.R., FERGUSON-DARNELL, B., COLLINS, P.A., BUCK, D., and TERSTAPPEN, L.W. (1993). Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J. Immunol. 150, 1105-1121.
24. POULIN, J.F., VISWANATHAN, M.N., HARRIS, J.M., KOMANDURI, K.V., WIEDER, E., RINGUETTE, N., JENKINS, M., MCCUNE, J.M., and SEKALY, R.P. (1999). Direct evidence for thymic function in adult humans. J. Exp. Med. 190, 479-486.
25. RANGA, U., WOFFENDIN, C., VERMA, S., XU, L., JUNE, C.H., BISHOP, D.K., and NABEL, G.J. (1998). Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals. Proc. Natl. Acad. Sci. U.S.A. 95, 1201-1206.
26. RIDDELL, S.R., ELLlOTT, M., LEWINSOHN, D.A., GILBERT, M.J., WILSON, L., MANLEY, S.A., LUPTON, S.D., OVERELL, R.W., REYNOLDS, T.C., COREY, L., and GREENBERG, P.D. (1996). T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2, 165-167.
27. ROE, T., REYNOLDS, T.C., YU, G., and BROWN, P.O. (1993). Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12, 2099-2108.
28. SANDERS, M.E., MAKGOBA, M.W., and SHAW, S. (1988). Human naive and memory T cells: Reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today 9, 195-199.
29. SMITH, K.Y., VALDEZ, H., LANDAY, A., SPRITZLER, J., KESSLER, H.A., CONNICK, E., KURITZKES, D., GROSS, B., FRANCIS, I., MCCUNE, J.M., and LEDERMAN, M.M. (2000). Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, larnivudine, and ritonavir therapy. J. Infect. Dis. 181, 141-147.
30. SUN, L.Q., WARRILOW, D., WANG, L., WITHERINGTON, C., MACPHERSON, J., and SYMONDS, G. (1994). Ribozyme-mediated suppression of Moloney murine leukemia virus and human immunodeficiency virus type I replication in permissive cell lines. Proc. Natl. Acad. Sci. U.S.A. 91, 9715-9719.
31. SUN, L.Q., PYATI, J., SMYTHE, J., WANG, L., MACPHERSON, J., GERLACH, W., and SYMONDS, G. (1995a). Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs. Proc. Natl. Acad. Sci. U.S.A. 92, 7272-7276.
32. SUN, L.Q., WANG, L., GERLACH, W.L., and SYMONDS, G. (1995b). Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res. 23, 2909-2913.
33. WANG, L., WITHERINGTON, C., KING, A., GERLACH, W.L., CARR, A., PENNY, R., COOPER, D., SYMONDS, G., and SUN, L.Q. (1998). Preclinical characterization of an anti-tat ribozyme for therapeutic application. Hum. Gene Ther. 9, 1283-1291.
34. ZHANG, L., LEWIN, S.R., MARKOWITZ, M., LIN, H.H., SKULSKY, E., KARANICOLAS, R., HE, Y., JIN, X., TUTTLETON, S., VESANEN, M., SPIEGEL, H., KOST, R., VAN LUNZEN, J., STELLBRINK, H.J., WOLINSKY, S., BORKOWSKY, W., PALUMBO, P., KOSTRIKIS, L.G., and HO, D.D. (1999). Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J. Exp. Med. 190, 725-732.
35. ZHU, T., MUTHUI, D., HOLTE, S., NICKLE, D., FENG, F., BRODIE, S., HWANGBO, Y., MULLINS, J.I., and COREY, L. (2002). Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76, 707-716.